Achievements of UZH Spin-offs

UZH Spin-offs are impressive both in their development and their success – the latest news is outlined below:

ZuriMED Team

08.09.2026 | UZH Spin-Off ZuriMED has signed a definitive agreement to be acquired by global medical technology company Stryker. The acquisition will bring ZuriMED’s FDA-cleared FiberLocker® System into Stryker’s portfolio, marking an important milestone for the company.

Founded in 2009, ZuriMED specializes in orthopedic biomechanics and biomaterials. Its FiberLocker® System addresses a key challenge in rotator cuff repair by mechanically reinforcing the injured tendon, providing immediate structural support and aiming to improve the stability of the repair and healing process. The FiberLocker® System received FDA clearance in February 2025 and is already commercially available. With the acquisition, Stryker aims to expand its rotator cuff augmentation portfolio and strengthen its offering in shoulder care.

ZuriMED News
ZuriMED

Yannick Devaud, Founder and CEO KoveMedical

03.09.2026 | KOVE Medical, a MedTech spin-off of the University of Zurich and University Hospital Zurich, has successfully closed a CHF 1.6 million financing round. The funding was secured with the support of a syndicate of angel investors and marks an important milestone in the company’s development.

KOVE Medical is developing an amniotic sac closure device designed to reduce the risk of preterm birth following fetoscopic interventions during pregnancy. With the new funding, the company will advance its technology from preclinical development towards First-in-Human (FIH) studies, bringing the solution one step closer to clinical application.

Founder and CEO Yannick Devaud was awarded a UZH Entrepreneur Fellowship in 2019. 

Kove Medical

Burcu Demiray, Founder & Managing Director Novapreneurs

22.07.2026 | Novapreneurs has launched as a platform supporting experienced professionals in turning their expertise into entrepreneurial ventures. Through a blended learning programme, practical support and a peer community, Novapreneurs helps professionals navigate the transition into entrepreneurship and provides structured training and resources along the way.

Novapreneurs originated at the University of Zurich Healthy Longevity Center and was supported by the UZH Innovation Hub through the founder's, Burcu Demiray, Entrepreneur Fellowship in 2026. With its official launch, the programme and its resources are now publicly available.

Novapreneurs

Delta Labs Team

07.04.2026 | The UZH Startup Delta Labs has raised EUR 4.4 million in a seed round led by Cusp Capital and Auxxo Female Catalyst Fund. The company develops AI-powered customer simulation tools that help businesses anticipate how customers will respond to decisions before they are made. With this round of funding, they are investing in the further development of Elaiia, their AI-powered customer simulation platform and in the continued expansion of their team.  
Delta Labs was founded in 2022 by Anne Scherer, a former University of Zurich professor and Cindy Candrian, who completed her PhD at UZH. The company was awarded the UZH Startup Label. 
Article startupticker.ch

23.03.2026 | At the University of Zurich, basic research brings about innovative products and applications that help improve many people’s lives. Researchers filed 27 patent and trademark applications and 57 inventions in 2025, and four new Spin-offs were created. This has resulted in an excellent track record: the number of Spin-offs from UZH since 1999 now stands at 165.
Innovation article and Spin-off portraits
Full Article at UZH News

Valentina Vongrad, CSO FimmCyte

16.03.2026 | The UZH Spin-off has entered a strategic research collaboration with Gedeon Richter Plc. to develop a potential new treatment for endometriosis. The project focuses on FMC2, a therapy designed to target the underlying cause of the disease, which affects around one in ten women worldwide. FimmCyte will work with Gedeon Richter to advance the program through preclinical development toward first clinical studies. 
Co-founder and CSO Valentina Vongrad was awarded a UZH Entrepreneur Fellowship in 2022.
Full Article
News FimmCyte

Foto Wyss Zurich

15.01.2026 | Bio-engineered skin grafts can play an important role in the treatment of burn victims. Researchers at UZH have been working on new approaches for such grafts for over 15 years. This work led to the creation of Cutiss in 2017, a spin-off that produces living skin tissue from the patients’ own cells. 
UZH article "New Skin for Burn Victims"

Claudia Scheckel, CEO Oncobit

03.12.2025 | The UZH Spin-off has successfully secured CHF 1.9 million in a new financing round. The additional capital will support the company's clinical developments for next-generation cancer monitoring solutions and broaden its reach into new markets.
Entire news story
Oncobit announcement

CUTISS Team

22.09.2025 | The UZH Spin-off has successfully raised 56 CHF million in a Series C financing round. This investment will support the ongoing Phase 3 studies on denovoSkin™ and prepare for its market launch.
Entire news story
CUTISS announcement
 

08.09.2025 | Since 2011 the TOP 100 Swiss Startup Ranking has been selecting the most promising young companies in Switzerland. The 2025 ranking shows the UZH's outstanding role as a nurturing group for innovative life sciences startups. Special Congratulations to MUVON that makes it Top 3 in BioTech and to the Newcomers MetaLead and Nerai Biosciences!

Entire news story
TOP 100 Swiss Startup Ranking

Dario Dornbirer, Co-Founder

22.08.2025 | The UZH Spin-off has successfully emerged from stealth mode and is on track to bring its groundbreaking therapies for neuropsychiatric disorders to patients. Through novel, specifically developed pharmacological agents, they are developing therapies for neuropsychiatric disorders such as PTSD, anxiety disorders, insomnia, and addiction. 

Entire news story

askEarth Team

25.07.2025 | With an intuitive search engine for satellite data, the UZH Spin-off is putting Earth observation at the fingertips of the public – and has now received CHF 2.26 million to scale up its operations. askEarth was founded in 2022 as a UZH spin-off. Co-founder and CTO Simon Grüning was awarded a UZH Entrepreneur Fellowship in 2022. 

Entire news story
Entrepreneurship Fellow Profile Simon Grüning

Michal Shoshan

22.08.2025 | The UZH Spin-off announces a CHF 1 million funding from the UZH Life Sciences Fund. metaLead is developing a new class of metal-binding drugs aimed at overcoming the shortcomings of existing chelation therapies. Michal Soshan was awarded a UZH Entrepreneur Fellowship in 2023. 

Entire news story
Entrpreneur Fellow Profile Michal Shoshan